CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 143 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01823328
NCT01823328Phase 4Completed
CompareCT.gov

Ketamine Versus Etomidate for Sedation of Emergency Department Patients During Rapid Sequence Intubation

Hennepin Healthcare Research Institute·interventional·Posted Apr 4, 2013·Updated May 24, 2019

In Brief

A Phase 4 clinical trial evaluating Ketamine and Etomidate for Airway Control and 3 related conditions. Completed, enrolled 143 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAirway Control, Anesthesia, Intubation, Complication
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 4, 2013
Enrollment StartSep 1, 2013
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 13.2 years ago

Interventions

Ketaminedrug

Subjects will receive ketamine for sedation prior to rapid sequence intubation.

Etomidatedrug

Subjects will receive etomidate for sedation prior to rapid sequence intubation.